Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

BACKGROUND: Biomarkers have the potential to guide treatment selection and clinical care in metastatic renal cell carcinoma (mRCC) in an expanding treatment landscape. We report baseline neutrophil-to-eosinophil ratios (NER) in patients with mRCC treated with immune checkpoint inhibitors (CPIs) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Tony Z, Ravindranathan, Deepak, Liu, Yuan, Martini, Dylan J, Brown, Jacqueline T, Nazha, Bassel, Russler, Greta, Yantorni, Lauren B, Caulfield, Sarah, Carthon, Bradley C, Kucuk, Omer, Master, Viraj A, Bilen, Mehmet Asim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Gastrointestinal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020802/
https://www.ncbi.nlm.nih.gov/pubmed/36427017
http://dx.doi.org/10.1093/oncolo/oyac236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020802/
https://www.ncbi.nlm.nih.gov/pubmed/36427017
http://dx.doi.org/10.1093/oncolo/oyac236

Ejemplares similares